BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34813414)

  • 1. Prostacyclin in Intubated Patients with COVID-19 and Severe Endotheliopathy: A Multicenter, Randomized Clinical Trial.
    Johansson PI; Søe-Jensen P; Bestle MH; Clausen NE; Kristiansen KT; Lange T; Stensballe J; Perner A
    Am J Respir Crit Care Med; 2022 Feb; 205(3):324-329. PubMed ID: 34813414
    [No Abstract]   [Full Text] [Related]  

  • 2. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial.
    Dushianthan A; Clark H; Madsen J; Mogg R; Matthews L; Berry L; de la Serna JB; Batchelor J; Brealey D; Hussell T; Porter J; Djukanovic R; Feelisch M; Postle A; Grocott MPW
    Trials; 2020 Dec; 21(1):1014. PubMed ID: 33302976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of prostacyclin infusion on markers of endothelial activation and damage in mechanically ventilated patients with SARS-CoV-2 infection.
    Vigstedt M; Søe-Jensen P; Bestle MH; Clausen NE; Kristiansen KT; Lange T; Stensballe J; Perner A; Johansson PI
    J Crit Care; 2022 Jun; 69():154010. PubMed ID: 35183892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
    Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
    Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of iloprost in patients with septic shock-induced endotheliopathy-Protocol for the multicenter randomized, placebo-controlled, blinded, investigator-initiated trial.
    Bestle MH; Clausen NE; Søe-Jensen P; Kristiansen KT; Lange T; Johansson PI; Stensballe J; Perner A
    Acta Anaesthesiol Scand; 2020 May; 64(5):705-711. PubMed ID: 31950481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial.
    Alhazzani W; Parhar KKS; Weatherald J; Al Duhailib Z; Alshahrani M; Al-Fares A; Buabbas S; Cherian SV; Munshi L; Fan E; Al-Hameed F; Chalabi J; Rahmatullah AA; Duan E; Tsang JLY; Lewis K; Lauzier F; Centofanti J; Rochwerg B; Culgin S; Nelson K; Abdukahil SA; Fiest KM; Stelfox HT; Tlayjeh H; Meade MO; Perri D; Solverson K; Niven DJ; Lim R; Møller MH; Belley-Cote E; Thabane L; Tamim H; Cook DJ; Arabi YM;
    JAMA; 2022 Jun; 327(21):2104-2113. PubMed ID: 35569448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized Phase 3 Trial of Ruxolitinib for COVID-19-Associated Acute Respiratory Distress Syndrome.
    Rein L; Calero K; Shah R; Ojielo C; Hudock KM; Lodhi S; Sadaka F; Bellam S; Palma C; Hager DN; Daniel J; Schaub R; O'Hayer K; Theodoropoulos NM
    Crit Care Med; 2022 Dec; 50(12):1701-1713. PubMed ID: 36226977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial.
    Grieco DL; Menga LS; Cesarano M; Rosà T; Spadaro S; Bitondo MM; Montomoli J; Falò G; Tonetti T; Cutuli SL; Pintaudi G; Tanzarella ES; Piervincenzi E; Bongiovanni F; Dell'Anna AM; Delle Cese L; Berardi C; Carelli S; Bocci MG; Montini L; Bello G; Natalini D; De Pascale G; Velardo M; Volta CA; Ranieri VM; Conti G; Maggiore SM; Antonelli M;
    JAMA; 2021 May; 325(17):1731-1743. PubMed ID: 33764378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial.
    Caricchio R; Abbate A; Gordeev I; Meng J; Hsue PY; Neogi T; Arduino R; Fomina D; Bogdanov R; Stepanenko T; Ruiz-Seco P; Gónzalez-García A; Chen Y; Li Y; Whelan S; Noviello S;
    JAMA; 2021 Jul; 326(3):230-239. PubMed ID: 34283183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial.
    Aman J; Duijvelaar E; Botros L; Kianzad A; Schippers JR; Smeele PJ; Azhang S; Bartelink IH; Bayoumy AA; Bet PM; Boersma W; Bonta PI; Boomars KAT; Bos LDJ; van Bragt JJMH; Braunstahl GJ; Celant LR; Eger KAB; Geelhoed JJM; van Glabbeek YLE; Grotjohan HP; Hagens LA; Happe CM; Hazes BD; Heunks LMA; van den Heuvel M; Hoefsloot W; Hoek RJA; Hoekstra R; Hofstee HMA; Juffermans NP; Kemper EM; Kos R; Kunst PWA; Lammers A; van der Lee I; van der Lee EL; Maitland-van der Zee AH; Mau Asam PFM; Mieras A; Muller M; Neefjes ECW; Nossent EJ; Oswald LMA; Overbeek MJ; Pamplona CC; Paternotte N; Pronk N; de Raaf MA; van Raaij BFM; Reijrink M; Schultz MJ; Serpa Neto A; Slob EMA; Smeenk FWJM; Smit MR; Smits AJ; Stalenhoef JE; Tuinman PR; Vanhove ALEM; Wessels JN; van Wezenbeek JCC; Vonk Noordegraaf A; de Man FS; Bogaard HJ
    Lancet Respir Med; 2021 Sep; 9(9):957-968. PubMed ID: 34147142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.
    ; Munch MW; Myatra SN; Vijayaraghavan BKT; Saseedharan S; Benfield T; Wahlin RR; Rasmussen BS; Andreasen AS; Poulsen LM; Cioccari L; Khan MS; Kapadia F; Divatia JV; Brøchner AC; Bestle MH; Helleberg M; Michelsen J; Padmanaban A; Bose N; Møller A; Borawake K; Kristiansen KT; Shukla U; Chew MS; Dixit S; Ulrik CS; Amin PR; Chawla R; Wamberg CA; Shah MS; Darfelt IS; Jørgensen VL; Smitt M; Granholm A; Kjær MN; Møller MH; Meyhoff TS; Vesterlund GK; Hammond NE; Micallef S; Bassi A; John O; Jha A; Cronhjort M; Jakob SM; Gluud C; Lange T; Kadam V; Marcussen KV; Hollenberg J; Hedman A; Nielsen H; Schjørring OL; Jensen MQ; Leistner JW; Jonassen TB; Kristensen CM; Clapp EC; Hjortsø CJS; Jensen TS; Halstad LS; Bak ERB; Zaabalawi R; Metcalf-Clausen M; Abdi S; Hatley EV; Aksnes TS; Gleipner-Andersen E; Alarcón AF; Yamin G; Heymowski A; Berggren A; La Cour K; Weihe S; Pind AH; Engstrøm J; Jha V; Venkatesh B; Perner A
    JAMA; 2021 Nov; 326(18):1807-1817. PubMed ID: 34673895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial.
    Muller M; Lefebvre F; Harlay ML; Glady L; Becker G; Muller C; Aberkane O; Tawk M; Julians M; Romoli A; Hecketsweiler S; Schneider F; Pottecher J; Chamaraux-Tran TN
    Trials; 2021 Feb; 22(1):131. PubMed ID: 33573681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.
    Murai IH; Fernandes AL; Sales LP; Pinto AJ; Goessler KF; Duran CSC; Silva CBR; Franco AS; Macedo MB; Dalmolin HHH; Baggio J; Balbi GGM; Reis BZ; Antonangelo L; Caparbo VF; Gualano B; Pereira RMR
    JAMA; 2021 Mar; 325(11):1053-1060. PubMed ID: 33595634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.